Zhao Xiaoya, Ding Han, Guo Aoxin, Zhong Xuemei, Zhou Siai, Wang Guoqing, Liu Yuhua, Ishiwata Akihiro, Tanaka Katsunori, Cai Hui, Liu Xue-Wei, Ding Feiqing
School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University Shenzhen 518107 China
School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University 637371 Singapore
Chem Sci. 2024 Jul 16;15(32):12889-12899. doi: 10.1039/d4sc03449j. eCollection 2024 Aug 14.
The capsular polysaccharide (CPS) is a major virulence factor of the pathogenic and a promising target for vaccine development. However, the synthesis of the 1,2--2-amino-2-deoxyglycoside core of CPS remains challenging to date. Here we develop a highly α-selective ZnI-mediated 1,2- 2-azido-2-deoxy chemical glycosylation strategy using 2-azido-2-deoxy glucosyl donors equipped with various 4,6--tethered groups. Among them the tetraisopropyldisiloxane (TIPDS)-protected 2-azido-2-deoxy-d-glucosyl donor afforded predominantly α-glycoside (α : β = >20 : 1) in maximum yield. This novel approach applies to a wide acceptor substrate scope, including various aliphatic alcohols, sugar alcohols, and natural products. We demonstrated the versatility and effectiveness of this strategy by the synthesis of K48 capsular pentasaccharide repeating fragments, employing the developed reaction as the key step for constructing the 1,2- 2-azido-2-deoxy glycosidic linkage. The reaction mechanism was explored with combined experimental variable-temperature NMR (VT-NMR) studies and mass spectroscopy (MS) analysis, and theoretical density functional theory calculations, which suggested the formation of covalent α-C1-iodide intermediate in equilibrium with separated oxocarbenium-counter ion pair, followed by an S1-like α-nucleophilic attack most likely from separated ion pairs by the ZnI-activated acceptor complex under the influence of the 2-azido effect.
荚膜多糖(CPS)是病原体的主要毒力因子,也是疫苗开发的一个有前景的靶点。然而,迄今为止,CPS的1,2--2-氨基-2-脱氧糖苷核心的合成仍然具有挑战性。在此,我们开发了一种高度α-选择性的ZnI介导的1,2- 2-叠氮基-2-脱氧化学糖基化策略,使用配备各种4,6--连接基团的2-叠氮基-2-脱氧葡萄糖基供体。其中,四异丙基二硅氧烷(TIPDS)保护的2-叠氮基-2-脱氧-d-葡萄糖基供体以最高产率主要提供α-糖苷(α : β =>20 : 1)。这种新方法适用于广泛的受体底物范围,包括各种脂肪醇、糖醇和天然产物。我们通过合成K48荚膜五糖重复片段证明了该策略的通用性和有效性,采用所开发的反应作为构建1,2- 2-叠氮基-2-脱氧糖苷键的关键步骤。通过结合实验变温核磁共振(VT-NMR)研究、质谱(MS)分析和理论密度泛函理论计算探索了反应机理,结果表明形成了与分离的氧鎓-抗衡离子对处于平衡的共价α-C1-碘化物中间体,随后在2-叠氮基效应的影响下,最有可能由ZnI活化的受体络合物从分离的离子对进行类似S1的α-亲核攻击。